HCA Healthcare Financial Statements (HCA)
|
|
|
|
Report date
|
|
|
20.02.2020 |
19.02.2021 |
18.02.2022 |
17.02.2023 |
16.02.2024 |
|
31.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
51 336 |
51 533 |
58 752 |
60 233 |
64 968 |
|
69 958 |
|
Operating Income, bln rub |
|
|
7 261 |
7 316 |
9 791 |
9 098 |
9 627 |
|
2 581 |
|
EBITDA, bln rub |
? |
|
9 664 |
9 735 |
14 252 |
13 290 |
12 721 |
|
9 059 |
|
Net profit, bln rub |
? |
|
3 505 |
3 754 |
6 956 |
5 643 |
5 242 |
|
1 156 |
|
|
OCF, bln rub |
? |
|
7 602 |
9 232 |
8 959 |
8 522 |
9 431 |
|
10 972 |
|
CAPEX, bln rub |
? |
|
4 158 |
2 835 |
3 577 |
4 395 |
4 744 |
|
4 944 |
|
FCF, bln rub |
? |
|
3 444 |
6 397 |
5 382 |
4 127 |
4 687 |
|
6 028 |
|
Dividend payout, bln rub
|
|
|
550.0 |
153.0 |
624.0 |
653.0 |
661.0 |
|
680.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
15.7% |
4.08% |
8.97% |
11.6% |
12.6% |
|
58.8% |
|
|
OPEX, bln rub |
|
|
35 637 |
35 902 |
39 593 |
41 809 |
45 439 |
|
58 552 |
|
Cost of production, bln rub |
|
|
8 481 |
8 369 |
9 481 |
9 371 |
9 902 |
|
61 719 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
1 824 |
1 584 |
1 566 |
1 741 |
1 938 |
|
2 042 |
|
|
Assets, bln rub |
|
|
45 058 |
47 490 |
50 742 |
52 438 |
56 211 |
|
59 459 |
|
Net Assets, bln rub |
? |
|
-2 808 |
572.0 |
-933.0 |
-2 767 |
-1 774 |
|
-2 182 |
|
Debt, bln rub |
|
|
35 221 |
32 677 |
36 334 |
39 836 |
41 859 |
|
44 889 |
|
Cash, bln rub |
|
|
621.0 |
1 793 |
1 451 |
908.0 |
1 022 |
|
2 888 |
|
Net debt, bln rub |
|
|
34 600 |
30 884 |
34 883 |
38 928 |
40 837 |
|
42 001 |
|
|
Ordinary share price, rub |
|
|
147.8 |
164.5 |
256.9 |
240.0 |
270.7 |
|
228.0 |
|
Number of ordinary shares, mln |
|
|
341.2 |
338.3 |
323.3 |
290.3 |
272.4 |
|
256.8 |
|
|
Market cap, bln rub |
|
|
50 434 |
55 633 |
83 066 |
69 672 |
73 734 |
|
58 539 |
|
EV, bln rub |
? |
|
85 034 |
86 517 |
117 949 |
108 600 |
114 571 |
|
100 540 |
|
Book value, bln rub |
|
|
-11 077 |
-8 006 |
-10 473 |
-12 420 |
-11 719 |
|
-12 164 |
|
|
EPS, rub |
? |
|
10.3 |
11.1 |
21.5 |
19.4 |
19.2 |
|
4.50 |
|
FCF/share, rub |
|
|
10.1 |
18.9 |
16.6 |
14.2 |
17.2 |
|
23.5 |
|
BV/share, rub |
|
|
-32.5 |
-23.7 |
-32.4 |
-42.8 |
-43.0 |
|
-47.4 |
|
|
EBITDA margin, % |
? |
|
18.8% |
18.9% |
24.3% |
22.1% |
19.6% |
|
12.9% |
|
Net margin, % |
? |
|
6.83% |
7.28% |
11.8% |
9.37% |
8.07% |
|
1.65% |
|
FCF yield, % |
? |
|
6.83% |
11.5% |
6.48% |
5.92% |
6.36% |
|
10.3% |
|
ROE, % |
? |
|
-124.8% |
656.3% |
-745.6% |
-203.9% |
-295.5% |
|
-53.0% |
|
ROA, % |
? |
|
7.78% |
7.90% |
13.7% |
10.8% |
9.33% |
|
1.94% |
|
|
P/E |
? |
|
14.4 |
14.8 |
11.9 |
12.3 |
14.1 |
|
50.7 |
|
P/FCF |
|
|
14.6 |
8.70 |
15.4 |
16.9 |
15.7 |
|
9.71 |
|
P/S |
? |
|
0.98 |
1.08 |
1.41 |
1.16 |
1.13 |
|
0.84 |
|
P/BV |
? |
|
-4.55 |
-6.95 |
-7.93 |
-5.61 |
-6.29 |
|
-4.81 |
|
EV/EBITDA |
? |
|
8.80 |
8.89 |
8.28 |
8.17 |
9.01 |
|
11.1 |
|
Debt/EBITDA |
|
|
3.58 |
3.17 |
2.45 |
2.93 |
3.21 |
|
4.64 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
8.10% |
5.50% |
6.09% |
7.30% |
7.30% |
|
7.07% |
|
| HCA Healthcare shareholders |
